<!doctype html>
<html lang="en" data-bs-theme="dark">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Research — Laura Díaz Sáez Lab</title>

  <!-- Bootstrap CSS -->
  <link
    href="https://cdn.jsdelivr.net/npm/bootstrap@5.3.3/dist/css/bootstrap.min.css"
    rel="stylesheet"
    integrity="sha384-QWTKZyjpPEjISv5WaRU9OFeRpok6YctnYmDr5pNlyT2bRjXh0JMhjY6hW+ALEwIH"
    crossorigin="anonymous"
  >

  <link rel="stylesheet" href="assets/site.css?v=1100">

  <style>
    .pub-section h3 {
      font-size: 1.5rem;
      margin-top: 0.5rem;
      margin-bottom: 0.75rem;
    }
    .year-pills a { margin: 0.2rem; }
    .year-title {
      margin-top: 2rem;
      margin-bottom: .75rem;
      border-left: 4px solid #6c757d;
      padding-left: 10px;
      color: #e0e0e0;
    }
    .pub-list ul {
      padding-left: 1rem;
      margin-bottom: 0;
    }
    .pub-list li {
      margin-bottom: .85rem;
      line-height: 1.5;
    }
    .pub-meta { font-style: italic; }
    .pub-actions a { text-decoration: underline; }
  </style>
</head>
<body class="d-flex text-center inner-page">
  <div class="cover-container d-flex w-100 p-3 flex-column">

<!-- Top navigation (like the example site) -->
    <header class="mb-auto text-center">
      <div>
        <h3 class="mb-3">Antimicrobial Discovery Lab</h3>
        <nav class="nav nav-masthead justify-content-center">
        <a class="nav-link fw-semibold" href="index.html">Home</a>
        <a class="nav-link fw-semibold active" aria-current="page" href="research.html">Research</a>
        <a class="nav-link fw-semibold" href="collaborations.html">Collaborations</a>
        <a class="nav-link fw-semibold" href="people.html">People</a>
        <a class="nav-link fw-semibold" href="publications.html">Publications</a>
        <a class="nav-link fw-semibold" href="join.html">Join us</a>
      </nav>
      </div>
    </header>

    <main class="px-3">
      <h1 class="display-4 text-center mb-5">Our Research</h1>
      <p class="lead mb-4">
        Laboratory of Structural Biology, Enzymology, and Biophysics dedicated to
        the generation of new classes of antimicrobials. Our research primarily focuses
        on tuberculosis, with additional projects on ESKAPE pathogens and intracellular organisms.
        We collaborate with international groups, including experts in medicinal chemistry and microbiology.
      </p>
    </main>
    
<!-- Projects grid -->
<section class="container py-5 text-start">
  <h2 class="mb-4 text-center">Current Projects</h2>
  <div class="row g-4">
    <!-- Project A: Multitargeting antimicrobials -->
    <div class="col-md-6">
      <div class="card h-100 bg-body-tertiary">
        <!-- Optional image: place an img here -->
        <!-- <img src="assets/project-a.jpg" class="card-img-top" alt="Project A"> -->
        <div class="card-body">
          <h3 class="card-title h4 mb-3 text-center">Multitargeting antimicrobials</h3>
          <figure class="mt-3 text-center">
            <img src="assets/figures/Project1.png" 
                 class="img-fluid rounded shadow-sm" 
                 alt="Structural representation of Mur ligases project">
          </figure>
          <p class="card-text" style="text-align: justify;">
            The OSA project.
            The group is a member of the international Open-Source Antibiotics consortium (OSA), which brings
            together institutions from Spain, United Kingdom and USA to accelerate the development of new antimicrobials. 
            This collaboration integrates leading expertise in bacterial biochemistry, chemistry, genetics, physiology, and microbiology, 
            with a particular focus on peptidoglycan metabolism, structure, and architecture. The central aim is to design drug-like molecules 
            capable of inhibiting multiple structurally related enzymes, reducing the likelihood of antimicrobial resistance, and we focused on 
            the protein family Mur ligases (MurC, MurD, MurE, and MurF). These enzymes catalyze consecutive steps in the cytoplasmic biosynthesis 
            of peptidoglycan layer, and are essential for bacterial survival. Although Mur ligases share structural similarities, they are remarkably 
            flexible, often adopting different open/close states and quaternary structures. For this reason, ligand–protein structural studies are 
            crucial to the project’s progress. At the IQF-CSIC, we use X-ray crystallography to obtain high-resolution structures of Mur ligases 
            from <i>Mycobaterium tuberculosis</i> and ESKAPE pathogens, in complex with natural substrates, cofactors, intermediates, and novel inhibitors. 
            These data are fundamental for the rational design of new inhibitors at OSA (OSA website).          </p>
          <ul class="mb-3">
            <li> ESKAPE pathogens &amp; Tuberculosis</li>
            <li> Mur ligases
            <li> X-ray crystallography &amp; structure-guided design</li>
            <li> Mechanism-of-action &amp; high-throughput screening</li>
          </ul>
          <a href="#" class="btn btn-primary btn-sm">Learn more</a>
        </div>
      </div>
    </div>

    <!-- Project B: Tackling tuberculosis: Reactivating host cell innate immune responses. -->
    <div class="col-md-6">
      <div class="card h-100 bg-body-tertiary">
        <!-- Optional image -->
        <!-- <img src="assets/project-b.jpg" class="card-img-top" alt="Project B"> -->
        <div class="card-body">
          <h3 class="card-title h4 mb-3 text-center">Tackling tuberculosis: Reactivating host cell innate immune responses.</h3>
          <p class="card-text" style="text-align: justify;">
            <i>Mycobaterium tuberculosis</i> (<i>Mtb</i>) is a highly adaptable intracellular pathogen that employs multiple strategies to
            evade host innate immunity. Its complex cell wall limits compound permeability, together with its rapid adaptive responses
            under drug pressure drive the emergence of multi-drug resistance. To try overcoming these challenges, this project focuses
            on developing drug-like inhibitors that target <i>Mtb</i> proteins secreted into the host cytoplasm and actively suppress innate 
            immune responses. By inhibiting these proteins, we aim to restore host immune activity and identify new therapeutic avenues.
          </p>
          <ul class="mb-3">
            <li> Essential proteins during infection</li>
            <li> Cryo-EM / X-ray crystallography</li>
            <li> Kinetic assays &amp; inhibition profiling</li>
            <li> Protein degradation &amp; structure-guided design</li>
          </ul>
          <a href="#" class="btn btn-primary btn-sm">Learn more</a>
        </div>
      </div>
    </div>
  </div>
</section>

<hr class="my-5"> 

<!-- Funding Section -->
<section class="container py-5 text-start">
  <h2 class="mb-4 text-center">Funding</h2>

  <p class="lead text-center text-white-50 mb-5">
    <!-- Our research is supported by national and international funding agencies and collaborative programs.  -->
    <!-- We gratefully acknowledge the institutions and projects that make our work possible. -->
  </p>

  <div class="row g-4 align-items-center justify-content-center">

    <!-- Example 1 -->
    <div class="col-md-10">
      <div class="row align-items-center">
        <div class="col-md-9">
          <h5 class="fw-semibold mb-2">
            Atracción de Talento César Nombela, Gobierno de la Comunidad de Madrid, Spain
          </h5>
          <p class="small text-white-50 mb-1">Project 2024-T1/SAL-GL-31542</p>
          <p class="small text-white-50 mb-0">
            “Antimicrobial development against Tuberculosis.”
          <p class="small text-white-50 mb-0">
            From Feb 2025 to Feb 2030
          </p>
        </div>
        <div class="col-md-3 text-end">
          <img src="assets/funding/talento.png" class="img-fluid" alt="Talento Logo" style="max-height:80px;">
        </div>
      </div>
    </div>

  <hr class="my-5" style="opacity: 0.3;">

  <div class="text-center">
    <p class="text-white-50 mb-1">
      We also acknowledge the support of national and international collaborations, 
      access to research facilities, and open science initiatives.
    </p>
    <div class="d-flex flex-wrap justify-content-center gap-4 mt-3">
      <img src="assets/funding/osa.png" alt="EU Commission" style="height:80px;">
      <img src="assets/funding/warwick.png" alt="Marie Curie Actions" style="height:80px;">
      <img src="assets/funding/bicycle.png" alt="IQF-CSIC" style="height:80px;">
      <img src="assets/funding/ktherapeutics.png" alt="IQF-CSIC" style="height:80px;">
    </div>
  </div>
</section>

<!-- Footer -->
<footer class="mt-auto text-white-50 text-center py-4">
  <p class="mb-1">
    Cover template for <a href="https://getbootstrap.com" target="_blank" rel="noopener">Bootstrap</a>.
  </p>
  <p class="mb-0">
    <span id="year"></span> Laura Díaz Sáez Research Group
  </p>
</footer>


  <!-- Bootstrap JS (optional, but small and handy) -->
  <script
    src="https://cdn.jsdelivr.net/npm/bootstrap@5.3.3/dist/js/bootstrap.bundle.min.js"
    integrity="sha384-YvpcrYf0tY3lHB60NNkmXc5s9fDVZLESaAA55NDzOxhy9GkcIdslK1eN7N6jIeHz"
    crossorigin="anonymous"></script>

  <script src="https://cdn.jsdelivr.net/npm/bootstrap@5.3.3/dist/js/bootstrap.bundle.min.js"></script>
  <script>document.getElementById('year').textContent = new Date().getFullYear();</script>

</body>
</html>
